| Health / Medical Topics |
Human Papillomavirus 16 E7 Peptide/Padre 965.10
A synthetic agent derived from human papillomavirus (HPV) E7 nuclear protein which is used to produce vaccines against HPV infection and HPV-related neoplasms. HPV E7 oncogenic protein binds the retinoblastoma tumor suppressor protein, pRB, as well as a number of other cellular proteins, and serves as a transcriptional activator. This protein is important in the induction and maintenance of cellular transformation and is co-expressed in the majority of HPV-containing carcinomas. PADRE(R) is a proprietary family of molecules that enhances the immune systems response against an administered immunogen such as the HPV E7 nuclear protein. (NCI Thesaurus)
YOU MAY ALSO LIKE
A peptide vaccine consisting of amino acids 12 through 20 of the viral oncoprotein human papillomavirus (HPV) 16 E7. Vaccination with HPV-16…
A type of virus that can cause abnormal tissue growth (for example, warts) and other changes to cells. Infection for a long…
A recombinant vaccine of different types of HPV proteins which are well-conserved within types with a significant inter-type variation.
A vaccine formulation consisting of several types of human papillomavirus (HPV)-derived noninfectious virus-like particles (VLPs) with potential immunoprophylactic activity. Upon administration, HPV…
The process of manufacturing non-prescription medications for humans by a pharmaceutical company.
The process of distributing non-prescription medications for human use.
